A detailed history of Bourne Lent Asset Management Inc transactions in Boston Scientific Corp stock. As of the latest transaction made, Bourne Lent Asset Management Inc holds 17,769 shares of BSX stock, worth $1.54 Million. This represents 0.57% of its overall portfolio holdings.

Number of Shares
17,769
Previous 17,769 -0.0%
Holding current value
$1.54 Million
Previous $1.37 Million 8.85%
% of portfolio
0.57%
Previous 0.52%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 23, 2023

BUY
$39.56 - $47.22 $1,978 - $2,361
50 Added 0.28%
17,769 $0
Q4 2020

Jan 27, 2021

SELL
$33.15 - $41.97 $2,320 - $2,937
-70 Reduced 0.39%
17,719 $637,000
Q4 2017

Feb 06, 2018

BUY
$24.79 - $29.8 $54,166 - $65,113
2,185 Added 14.0%
17,789 $441,000
Q3 2017

Oct 16, 2017

BUY
$26.26 - $29.17 $409,761 - $455,168
15,604
15,604 $455,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $124B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Bourne Lent Asset Management Inc Portfolio

Follow Bourne Lent Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bourne Lent Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bourne Lent Asset Management Inc with notifications on news.